Wearable Patch Can Be Beneficial In Monitoring Physiological Parameters, Drug Delivery, Disease Monitoring
Wearable Patch |
Body-worn patch solutions can be used for disease monitoring, drug delivery and diagnostics. They offer a comfortable, convenient alternative to existing care protocols and can encourage patient compliance, resulting in better outcomes. They are also less expensive than traditional medical devices and can provide real-time information that can be accessed from anywhere. However, the implementation of these innovations can still be challenging for many healthcare providers.
Wearable Patch
can be embedded with a variety of off-the-shelf sensors to monitor a range of
physiological parameters such as temperature, blood oxygenation and movement.
They are designed to be flexible and thin, making them comfortable and easy to
wear. They can be used to monitor a wide range of health conditions including
diabetes, heart disease, and respiratory diseases.
The Global Wearable Patch Market
Is Estimated To Be Valued At US$ 718.8 Million In 2023 And Is Expected To Exhibit A CAGR Of 23.0% During The Forecast Period (2023-2030).
These sensors can be combined with
wireless transmitters to connect the wearable device to a smartphone or
computer for data collection and analysis. These technologies allow the device
to send real-time alerts when a certain physiologic change is detected. They
can also store results for post-use analysis, allowing providers to study
trends over time.
Several companies have launched Wearable Patch for disease monitoring
and drug delivery applications. In the case of disease monitoring, these
systems can alert patients to changes in their condition and help them take
action in a timely manner. For drug delivery, these devices can deliver drugs
to specific sites within the body, such as a diabetic wound site.
These systems can be programmed to
release a specific dose of a drug at an appropriate time. This technology has
the potential to improve the delivery of medications, such as vaccines, which
can have limited efficacy when they are administered orally. These devices are
also undergoing additional research for use in chronic diseases such as cancer.
Moreover, the development of new technologies and materials, such as wearable
micro LED patches that inhibit UV-induced melanogenesis, can further enable
these devices to monitor and treat various conditions.
A smart insulin patch can be paired
with a mobile phone app that monitors glucose levels and delivers medication to
the appropriate site in response. This can reduce the frequency of hypoglycemic
events and prevent long-term damage to the diabetic wound.
Philips gained
approval from the US FDA for their disposable wearable sensor patch, Philips
Biosensor BX100 in May 2020. These sensor patches can help in tracking heart rate and respiratory rate after
the patient is discharged from the ICU.
Comments
Post a Comment